{"id":52134,"date":"2022-12-19T17:02:31","date_gmt":"2022-12-19T16:02:31","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/"},"modified":"2022-12-19T17:02:31","modified_gmt":"2022-12-19T16:02:31","slug":"arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/","title":{"rendered":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision"},"content":{"rendered":"
\n

\nAs uncertainty builds over access to reproductive healthcare, a Congressional bill seeks to eliminate obstacles to IVF and other treatments<\/i>\n<\/p>\n

<\/a><\/p>\n

CUPERTINO, Calif.–(BUSINESS WIRE)–ARC Fertility<\/a>, a pioneer in increasing access to quality family-forming benefits for employers, today announced its full support for the Right to Build Families Act,<\/a> introduced by Senators Tammy Duckworth (IL) and Patty Murray (WA) and Representative Susan Wild (PA-7). The Act was proposed in the wake of the Supreme Court\u2019s Dobbs v. Jackson Women’s Health decision, which erodes protections for reproductive rights.\n<\/p>\n

\n\u201cNo one knows what the long-term effects of the Dobbs decision will be, but it is likely that certain kinds of reproductive medicine will face restrictions or outright bans,\u201d says reproductive endocrinologist David Adamson, MD, founder and CEO of ARC Fertility. \u201cThis proposed law will codify the rights of Americans to receive reproductive therapies and protect healthcare workers who offer these family-forming services. Most importantly, it provides federal protections for people in states where reproductive medical rights are under attack and allows the federal government to sue states that deny access to care.\u201d\n<\/p>\n

\nExperts are predicting that in the next two years the Supreme Court might remove accepted protections for same-sex couples, trans individuals, and interracial couples. As a result, earlier this year Congress passed bipartisan legislation to limit the rights of states to pass legislation that could be discriminatory. \u201cThe Right to Build Families Act is necessary because reproductive rights in this country are under attack, and people deserve a chance to form and grow their families without the possibility of prosecution,\u201d Adamson adds.\n<\/p>\n

\nAbout ARC\u00ae <\/sup>Fertility<\/b>\n<\/p>\n

\nARC Fertility<\/a>\u00ae was founded in 1997 because of its passion to increase access to affordable high-quality reproductive care for everyone. Our mission is being accomplished through our national network of top-tier fertility clinics that deliver fertility and family-forming employer benefits, as well as evidence-based treatment packages and financing directly to patients. ARC Fertility has helped tens of thousands of people create the family of their dreams.\n<\/p>\n

Contacts<\/b> <\/p>\n

\nMedia contact:<\/b>
Richard Berman
\n
(647) 294-8372
\n
richard@verbfactory.com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

As uncertainty builds over access to reproductive healthcare, a Congressional bill seeks to eliminate obstacles to IVF and other treatments CUPERTINO, Calif.–(BUSINESS WIRE)–ARC Fertility, a pioneer in increasing access to quality family-forming benefits for employers, today announced its full support for the Right to Build Families Act, introduced by Senators Tammy Duckworth (IL) and Patty … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52134","6":"format-standard","7":"category-industry"},"yoast_head":"\nARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"As uncertainty builds over access to reproductive healthcare, a Congressional bill seeks to eliminate obstacles to IVF and other treatments CUPERTINO, Calif.–(BUSINESS WIRE)–ARC Fertility, a pioneer in increasing access to quality family-forming benefits for employers, today announced its full support for the Right to Build Families Act, introduced by Senators Tammy Duckworth (IL) and Patty ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-19T16:02:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision\",\"datePublished\":\"2022-12-19T16:02:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/\"},\"wordCount\":364,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005498\\\/en\\\/1668609\\\/21\\\/ARC_logo_for_web.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/\",\"name\":\"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005498\\\/en\\\/1668609\\\/21\\\/ARC_logo_for_web.jpg\",\"datePublished\":\"2022-12-19T16:02:31+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005498\\\/en\\\/1668609\\\/21\\\/ARC_logo_for_web.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221219005498\\\/en\\\/1668609\\\/21\\\/ARC_logo_for_web.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/","og_locale":"en_US","og_type":"article","og_title":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend","og_description":"As uncertainty builds over access to reproductive healthcare, a Congressional bill seeks to eliminate obstacles to IVF and other treatments CUPERTINO, Calif.–(BUSINESS WIRE)–ARC Fertility, a pioneer in increasing access to quality family-forming benefits for employers, today announced its full support for the Right to Build Families Act, introduced by Senators Tammy Duckworth (IL) and Patty ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-19T16:02:31+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision","datePublished":"2022-12-19T16:02:31+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/"},"wordCount":364,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/","url":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/","name":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg","datePublished":"2022-12-19T16:02:31+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221219005498\/en\/1668609\/21\/ARC_logo_for_web.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/arc-fertility-announces-support-for-right-to-build-families-act-to-guarantee-access-to-reproductive-medical-treatments-in-wake-of-dobbs-decision\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ARC Fertility Announces Support for \u201cRight to Build Families Act\u201d to Guarantee Access to Reproductive Medical Treatments in Wake of Dobbs Decision"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52134"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52134\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}